Press "Enter" to skip to content

Covaxin Phase-I human clinical trial begins at AIIMS, man given first dose: All you need to know

Countries across the world are in the race to develop a vaccine, and many of them, including India, are conducting human clinical trials to test the efficacy. The phase-I human clinical trial of Covaxin, India’s first indigenously-developed vaccine against coronavirus, began at the All India Institute of Medical Sciences (AIIMS) in Delhi today. 

Leave your comments

%d bloggers like this: